Cite

    Gibson, A. et al. (n.d.). 31 A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of a bioengineered allogeneic cellularized construct in patients with deep partial-thickness thermal burns. Journal of burn care & research. 42 (1), p. . [Online].